Delving into the Latest Updates on Jiangsu Mendel Gene Technology Co Ltd with Synapse

Overview

Tags

Digestive System Disorders

Infectious Diseases

Therapeutic vaccine

Synthetic peptide vaccine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Infectious Diseases	1

Top 5 Drug Type	Count

Therapeutic vaccine	1
Synthetic peptide vaccine	1

Primary objective: To compare the efficacy of sequential administration of therapeutic (synthetic peptide) hepatitis B vaccine and entecavir capsules with entecavir capsules alone in the treatment of chronic hepatitis B. Secondary objective: To observe the safety of sequential administration of therapeutic (synthetic peptide) hepatitis B vaccine and entecavir capsules in the treatment of chronic hepatitis B.

Start Date11 May 2021

Sponsor / Collaborator

Jiangsu Mendel Gene Technology Co Ltd

100 Clinical Results associated with Jiangsu Mendel Gene Technology Co Ltd

Login to view more data

0 Patents (Medical) associated with Jiangsu Mendel Gene Technology Co Ltd

Login to view more data

100 Deals associated with Jiangsu Mendel Gene Technology Co Ltd

Login to view more data

100 Translational Medicine associated with Jiangsu Mendel Gene Technology Co Ltd

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 30 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 3 Clinical

1

Login to view more data